Targeting SLMAP-ALK-a novel gene fusion in lung adenocarcinoma.
Adenocarcinoma of Lung
/ diagnostic imaging
Aged
Anaplastic Lymphoma Kinase
/ genetics
Carcinoma, Non-Small-Cell Lung
/ diagnostic imaging
Crizotinib
/ therapeutic use
Gene Fusion
Humans
Lung Neoplasms
/ diagnostic imaging
Male
Membrane Proteins
/ genetics
Protein Kinase Inhibitors
/ therapeutic use
lung adenocarcinoma
Journal
Cold Spring Harbor molecular case studies
ISSN: 2373-2873
Titre abrégé: Cold Spring Harb Mol Case Stud
Pays: United States
ID NLM: 101660017
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
04
01
2019
accepted:
08
03
2019
entrez:
5
6
2019
pubmed:
5
6
2019
medline:
27
5
2020
Statut:
epublish
Résumé
Assessment of
Identifiants
pubmed: 31160357
pii: mcs.a003939
doi: 10.1101/mcs.a003939
pmc: PMC6549559
pii:
doi:
Substances chimiques
Membrane Proteins
0
Protein Kinase Inhibitors
0
SLMAP protein, human
0
Crizotinib
53AH36668S
ALK protein, human
EC 2.7.10.1
Anaplastic Lymphoma Kinase
EC 2.7.10.1
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2019 Pagan et al.; Published by Cold Spring Harbor Laboratory Press.
Références
Clin Cancer Res. 2012 Sep 1;18(17):4682-90
pubmed: 22912387
J Transl Med. 2015 Feb 15;13:61
pubmed: 25880194
Mol Cancer Res. 2018 Nov;16(11):1724-1736
pubmed: 30002191
Cancer Cytopathol. 2015 Mar;123(3):162-70
pubmed: 25557162
J Clin Oncol. 2016 Oct 1;34(28):3383-9
pubmed: 27354483
Arch Pathol Lab Med. 2018 Mar;142(3):321-346
pubmed: 29355391
Circ Arrhythm Electrophysiol. 2012 Dec;5(6):1098-107
pubmed: 23064965
Oncogene. 2016 Sep 1;35(35):4549-57
pubmed: 26876214